Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00316537 · ClinicalTrials.gov registry record · Phase 1
Safety and Preliminary Efficacy Study of Nicotine Gel to Treat Diabetic Foot Ulcers
A Phase 1 study, sponsored by CoMentis.
- Terminated
- Registry status
- Phase 1
- Development phase
- 48
- Enrollment target
NCT00316537: Clinical Trial Phase 1 study, sponsored by CoMentis.
NCT00316537 is a Phase 1 study that was terminated before completion, run by CoMentis. The registered enrollment target is 48 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00316537, a Phase 1 study, was terminated before completion, sponsored by CoMentis.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 48 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and preliminary efficacy of low dose nicotine gel in patients with chronic diabetic ulcers
Interventions
- DRUG ATG002 (study drug)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2006-10 |
| Est. Completion | 2007-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00316537
The ClinicalTrials.gov registry entry for NCT00316537 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CoMentis, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ATG002 (study drug) is the first listed.
NCT00316537 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00316537 about?
NCT00316537 is a clinical study titled "Safety and Preliminary Efficacy Study of Nicotine Gel to Treat Diabetic Foot Ulcers". The purpose of this study is to evaluate the safety and preliminary efficacy of low dose nicotine gel in patients with chronic diabetic ulcers
What is the current status of trial NCT00316537?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 48 participants. The study started on 2006-10. Estimated completion is 2007-07.
What interventions are being tested in trial NCT00316537?
The interventions under investigation include: ATG002 (study drug) (DRUG).
Who is sponsoring clinical trial NCT00316537?
This trial is sponsored by CoMentis, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.